922170-67-0

Basic information

• Product Name: 4-BroMo-2-Methyl-6-iodoaniline
• Synonyms: 4-BroMo-2-Methyl-6-iodoaniline;4-Bromo-2-iodo-6-methylaniline;4-bromo-2-iodo-6-methylbenzenamine
• CAS NO: 922170-67-0
• Molecular Formula: C₇H₇BrIN
• Molecular Weight: 311.94565
• EINECS: -0
• Mol File: 922170-67-0.mol
• Article Data: 12

Chemical Properties

• Boiling Point: 302.8±42.0 °C(Predicted)
• Appearance: /
• Density: 2.133±0.06 g/cm3(Predicted)
• Storage Temp.: Keep in dark place,Sealed in dry,Room Temperature
• PKA: 1.69±0.10(Predicted)
• CAS DataBase Reference: 4-BroMo-2-Methyl-6-iodoaniline(CAS DataBase Reference)
• NIST Chemistry Reference: 4-BroMo-2-Methyl-6-iodoaniline(922170-67-0)
• EPA Substance Registry System: 4-BroMo-2-Methyl-6-iodoaniline(922170-67-0)

Safety Data

• Hazardous Substances Data: 922170-67-0(Hazardous Substances Data)

Usage

General Description

4-Bromo-2-methyl-6-iodoaniline is a chemical compound with the molecular formula C7H7BrIN. It is a halogenated aniline derivative and is also known by its CAS number 29388-59-4. It is primarily used as a building block in organic synthesis and can be utilized in the production of pharmaceuticals, agrochemicals, and other fine chemicals. 4-BroMo-2-Methyl-6-iodoaniline is considered to be hazardous and should be handled with care due to its toxic and potentially harmful properties. Its chemical structure contains a bromine and iodine atom attached to a benzene ring, along with a methyl group, making it a versatile intermediate for various chemical reactions and synthesis processes.

Upstream product

• 583-75-5 4-Bromo-2-methylaniline 

Downstream Products

• 922170-75-0 N-(4-bromo-2-iodo-6-methylphenyl)-N,2-dimethyl-(2E)-butenamide 
• 1092585-75-5 tert-butyl 4-bromo-2-iodo-6-methylphenylcarbamate 
• 116632-38-3 1-bromo-3-iodo-5-methylbenzene 
• 953410-86-1 5-bromo-7-iodo-1H-indazole 
• 1354311-05-9 C₁₆H₁₃BrINO 

Relevant articles and documents

Preparation method of 5-bromo-7-methylindole

The invention discloses a preparation method of 5-bromo-7-methylindole. The structure of an intermediate corresponds to a formula V. The preparation method comprises the following steps: using 4-bromo-2-methylaniline as an initial raw material, and carryi

Target-Based Identification and Optimization of 5-Indazol-5-yl Pyridones as Toll-like Receptor 7 and 8 Antagonists Using a Biochemical TLR8 Antagonist Competition Assay

Inappropriate activation of endosomal TLR7 and TLR8 occurs in several autoimmune diseases, in particular systemic lupus erythematosus (SLE). Herein, the development of a TLR8 antagonist competition assay and its application for hit generation of dual TLR7

ARYL, HETEROARY, AND HETEROCYCLIC PHARMACEUTICAL COMPOUNDS FOR TREATMENT OF MEDICAL DISORDERS

Complement Factor D inhibitors, pharmaceutical compositions, and uses thereof, as well as processes for their manufacture are provided. The compounds provided include Formula I, Formula II, Formula III, Formula IV, and Formula V, or a pharmaceutically acceptable salt, prodrug, isotopic analog, N-oxide, or isolated isomer thereof, optionally in a pharmaceutically acceptable composition. The inhibitors described herein target Factor D and inhibit or regulate the complement cascade.